Tofflon Life SciencesThe Business Unit focuses on the research and development of front-end technologies in the pharmaceutical and healthcare industries, delivering a comprehensive, one-stop service that integrates instruments, equipment, and consumables (including consumables, reagents, chromatography media, filtration products, packaging materials, etc.).
• In the field of cell therapy: providing comprehensive solutions for the preparation and manufacturing of immune cells, stem cells, tumor cell vaccines, and more;
• In the field of gene therapy: for nucleic acid drugs (mRNA/DNA),Viral Vector Drugsprovide integrated solutions for R&D and industrialization;
• In the field of biobanking: Develop automated sample storage and management systems, providing comprehensive solutions for cell and tissue banks;
• In the consumables sector: We have already established a presence in single-use bags (reaction bags/buffer preparation bags/storage bags), reagents (culture media/cryopreservation solutions), chromatography resins, and filtration (microfiltration/Deep Filtration/ultrafiltration/nanofiltration), rigid packaging materials have formed a comprehensive consumables solution;
• In the field of disinfection: dedicated to air and surface disinfection, infection control, terminal disinfection, andDisinfection of Multidrug-Resistant Organisms, providing comprehensive solutions for environmental disinfection.
Leveraging Tofflon Group’s mature capabilities in design, manufacturing, engineering construction, and nationwide after-sales service, Tofflon’s Life Science Division can serve the biopharmaceutical industry more rapidly and professionally.
